Matt Galsky and Tom Powles take the FDA and EMA approach respectively concerning adjuvant nivolumab for bladder cancer. ...
The Uromigos: Debate
Hear debates Thomas Powles, MD, and Brian Rini, MD, FASCO, debate industry research with GU experts.
Advertisement
Drs. David McDermott and Brian Rini debate treatment options in front-line renal cancer.
Dr. Bill Kaelin (Nobel Laureate) and Tom Powles (keen cyclist) extend their discussion from KCRS20 in the second Uromigos ...
Dr. Peter O'Donnell and Prof. Tom Powles debate front-line treatment options in urothelial cancer.
Matt Galsky tries to get to the bottom of whether these data has made any difference in treatment and future plans.
Advertisement
